Mushrooms may be key to answering “100–110% increase in global crop demand” by 2050

October 21, 2019 by Ethan Reyescrop, ThinkMyco, sustainability, agriculture, global warming, fungi, protein

A 2015 study found by 2050, Earth will need to increase crop yields by between 60% and 110% to sustain a rapidly expanding human populace.

We downloaded RLOVE, a dating app for psychonauts and “light warriors.” Here’s what happened

October 16, 2019 by Ethan Reyesdating app, Match Group, psychedelic, Tinder, RLAC, RLOVE

RLOVE is a new dating app designed “to connect awakened souls” who aren’t able to find partners through more traditional, tried and true means such as OkCupid.

Salvation Labs is growing a psychedelic division with cash from recreational cannabis sales

October 1, 2019 by Ethan Reyescannabis, Numinus, SLAB, salvation botanicals, salvation labs, michael tan, numinus, Nyquvest, Universal Ibogaine, psychedelic treatment

When walking through the woods, or even a particularly grassy side street, it is not uncommon to see mushrooms of the same variety sprouting up through the undergrowth.


Move over JUUL, psilocybin is the key to quitting smoking

October 31, 2019 by Ethan ReyesJUUL, COMPASS PATHWAYS, smoking cessation, depression, clinical trials

Psilocybin, a compound which has shown promise in counteracting treatment-resistant depression, leads the charge in helping JUUL users and smokers alike quit for good, according to a paper from Johns Hopkins University.

MindMed, owners of addiction-treating 18-MC, and Broadway Gold (BRD.V) announce definite arrangement for RTO

October 15, 2019 by Ethan ReyesIbogaine, 18-MC, mindmed, opioid use disorder, treatment, WEED.T, Bruce Linton, Shark Tank

MindMed, owners of the iboga-related 18-MC drug, is going public after firming up its reverse take-over of Broadway Gold Mining (BRD.V).

Yield Growth (BOSS.C) goes all in on #shroomboom with acquisition of recipes for Flourish Mushroom Labs

October 10, 2019 by Ethan ReyesYield Growth, Absolem, Flourish Mushroom Labs, reishi, turkey tail, cordyceps, lion's mane, BOSS.C, cancer

Yield Growth (BOSS.C) has decided not to proceed with the previously announced investment into Absolem Health, instead advancing with their own subsidiary, Flourish Mushroom Labs, which has completed its acquisition of edible mushroom formulas.

Why DARPA is reviving psychedelics research for the U.S. military in the shadow of MK-Ultra

October 10, 2019 by Ethan Reyes

On the 18-year anniversary of September 11, DARPA, the U.S. military research arm, said it was pursuing the development of fast-acting drugs to treat “chronic depression and post-traumatic stress.”